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This study aimed at describing an alternative surgical 
technique to the insertion of a ventilation tube in the 
tympanic membrane: myringotomy by radiofrequency 
alone and associated with mytomicin C. Aim: to show 
a surgical approach that can be simple to execute, not 
subject to complications arising from the ventilation tube. 
Materials and Methods: we compared myringotomy by 
microknife and by radiofrequency microcautery (0.3 mm 
and 0.7 mm tips) alone and associated with mytomicin 
C, considering the time of tympanic closure in Wistar 
rats. Experimental study. Results: there was a statistically 
significant difference between radiofrequency myringotomy 
and knife myringotomy. As we analyze the radiofrequency 
approach with the 0.7mm tip associated with mytomicin C 
(Wilcoxon test), the p value found was lower than 0.001, 
showing a statistical significance. The maximum tympanic 
membrane closure time was 44 days and the median found 
was 14 days. Conclusion: the radiofrequency myringotomy 
(with the larger diameter tip) associated with mytomicin C 
enhances the tympanic membrane healing time.
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INTRODUCTION 
Otitis media with effusion (OME) is socially and 
economically relevant, as this condition is considered the 
most common cause of hearing loss in childhood and a 
cause of speech impairment and poor achievement in 
school. According to the American Academy of Pediatrics 
and the American Academy of Otolaryngology and Head 
and Neck Surgery, about 90% of children have OME at 
any time before entering school, usually between ages 6 
months to 4 years. Most of these cases resolved sponta-
neously within 3 months.1 
Surgery is indicated in cases where the tympanic 
cavity effusion does not resolve spontaneously. The main 
purpose of surgery is to restore middle ear ventilation by 
eliminating negative intratympanic pressure. Thus, the 
mucosa is normalized, hair cells increase and the secretion 
potential is reduced.2-4 
Myringotomy with ventilation tube (VT) placement 
is the procedure of choice from the moment a patient 
becomes a candidate for surgery.1 This procedure is cur-
rently one of the most common surgeries in the US, and 
is the main reason children undergo general anesthesia.5 
Inserting VT in the tympanic membrane, however, 
may cause several complications. Several published studies 
have described the consequences of placing VT, the main 
ones being: otorrhea, tympanic membrane perforation 
following VT extrusion, retraction and tympanic atelectasis, 
tympanosclerosis, and VT retention for long periods.6-9 
Recent studies have demonstrated, by electron 
microscopy, the presence of biofilms on the surface of 
VTs. It has been suggested that bacterial clusters, named 
biofilms, are responsible for chronic otorrhea in patients 
undergoing tympanostomy with VT placement.10.11 
Aoki et al. showed that 2 months after tympanic 
cavity clearance, middle ear effusion and inflammation had 
regressed and pneumatic space had expanded.12 
In 1978, Saito et al. initiated studies of electrocautery 
myringotomies, proving that burns caused by this method 
resisted healing to a greater extent.13 
In 1982, Goode undertook the first CO
2
 laser myrin-
gotomy in humans.14,15 Since then, several studies on this 
technique have been published.16-18 
In 1994, the biomedical engineering department at 
our institution developed a device for performing highly 
precise and controllable electrosurgical microcauterization. 
Radiofrequency microelectrocautery has several advanta-
ges over other methods. The cost of operating this device 
ranges from 5 to 10% of laser costs. Furthermore, the tip 
is more accurate because it concentrates all the heat and 
different angles are possible according to the need. Laser 
may be limited by the angle of the incident rays.19.20 
The aim of our study was to evaluate the isolated 
microelectrocautery radiofrequency myringotomy techni-
que with mitomycin C in an animal model. This technique 
was compared with a microlancet approach. This study is 
thus part of a line of research aiming to investigated the 
various myringotomy techniques that are alternatives to 
VT insertion. 
METHODS 
This study was an experimental comparative trial 
done using Wistar rats, which was approved by the Insti-
tutional Review Board (number 03.173). Trichotomy was 
done prior to anesthesia for placing the microcautery pad. 
Anesthesia was attained using intramuscular ketamine (40-
90 mg/kg) and xylazine (5-13 mg/kg). 
A pilot study had demonstrated appropriate microe-
lectrocautery parameters, as follows: power level 8 (about 
30 watts) and temporized operation mode of 1.50 seconds. 
The study consisted of 3 groups. The right ear (RE) 
was the control group in all groups, in which microlancet 
myringotomy (ML-RE) was undertaken. In group 1 (n = 12), 
radiofrequency microelectrocautery myringotomy (RF-LE) 
was carried ou in the left ear (LE) using a 0.3 mm tip. In 
group 2 (n = 10), RF-LE was carried out with a 0.7 mm tip. 
In group 3 (n = 15), RF-LE was carried out with a 
0.7 mm tip, and associated with mitomycin C (RFMIT-LE). 
Following microcautery myringotomy, a small mitomycin 
C-soaked piece of gelfoam was placed for 10 minutes over 
the surgical wound and thereafter removed. The mitomycin 
C concentration was 0.4 mg/dl. 
Procedures were documented and recorded with 
a video camera attached to the surgical microscope (DF 
Vasconcelos). Follow-up examinations were done every 
4 days, and concluded upon healing (closure) of the 
myringotomy. The study was evaluated binomially, that is, 
myringotomies were either “open” or “closed.” Myringo-
tomy diameters were not measured in the days following 
the procedure. 
  
Statistical Analysis 
The median and interquartile range variables were 
described in the statistical analysis. The Wilcoxon test was 
applied for comparing right and left ears in each group. 
The Kruskal-Wallis test was applied for analyzing statistical 
differences among the left ears in the three groups. Due to 
variable asymmetry, rank transformation of the frequency 
values was done, after which the Tukey test was applied 
to detect differences among groups. The significance level 
was 5%. 
  
Calculation of the sample size 
Eleven rats in each group were needed for a di-
fference of 1.5 standard deviations among the means of 
different techniques (microlancet and radiofrequency 
myringotomy with or without mitomycin C) to be detected 
with a 90% statistical power and a 0.05 significance level. 
849
Brazilian Journal of otorhinolaryngology 75 (6) novemBer/DecemBer 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
RESULTS 
Analysis of the ML-RE in 22 rats in groups 1 and 2 
revealed that there was full healing in the entire sample 
within the first 3 days after the procedure. Results of the 
RF-LE technique, however, were more asymmetrical. In 
group 1 (RF-LE - 0.3 mm tip), the median was 5 days (P25 = 
3 days, P75 = 7 days). In group 2 (RF-LE - 0.7 mm tip), the 
calculated median was 10 days (P25 = 7 days, P75 = 14). 
In group 3 (ML-RE), the calculated median was 7 
days (P25 = 3 days, P75 = 7 days). The median calculated 
for the RFMIT-LE technique was 14 days (P25 = 10 days, 
P75 = 30 days). 
For groups 1 and 2, we analyzed statistically the 
right and left ears by applying the Wilcoxon test. The P 
value in the procedure was 0.023 mm with the 0.3 tip, and 
0.007 with the 0.7 mm tip. A comparison of the RF-OE 
technique in the two groups (0.3 and 0.7 mm tip) applying 
the Tukey test resulted in P = 0.017. 
The analysis of ML-RE with RFMIT-LE in the 15-rat 
sample in group 3 applying the Wilcoxon test found that 
P was lower, at 0.001. Comparing RFMIT-LE with RF-LE 
(0.3 mm tip) yielded a P value below 0.001; a comparison 
with the RF-LE (0.7 mm  tip) yielded a P  value equal to 
0.004 (Tukey test). 
DISCUSSION 
Alternatives to VT insertion have been developed 
to decrease complications associated with this procedu-
re. Several studies have been published, most of which 
have used the laser technique as an alternative method. 
Recent studies described below, however, have shown 
that radiofrequency as a surgical procedure has the same 
efficacy in terms of myringotomy patency time, as well as 
a number of advantages over the laser. 
Aoki et al. concluded that 2 months after treatment 
with VT insertion in the tympanic membrane, the middle 
ear effusion has disappeared, inflammation in the tym-
panic cavity had regressed, and the pneumatic area had 
expanded.12 This study supports the theory that 2 months 
of tympanic cavity clearance are enough for normalizing 
middle ear function. In our study, therefore, we decided 
to seek for a simpler myringotomy method that would 
implement and maintain tympanic patency for an appro-
ximately 2-month period. 
In our study, we used a radiofrequency technique 
(0.7 mm tip), and attained longer myringotomy patency. 
Both techniques (radiofrequency myringotomy with 0.7 
mm and 0.3 mm tips) showed a statistically significant 
difference compared to microlancet myringotomy. The 
maximum healing time was 21 days (0.7 mm tip); the 
median in this group was 10 days. 
Wang et al. found no correlation between the per-
foration size and healing time of tympanic perforation.21 
Our results diverge from these findings, as statistically 
significant longer healing times were observed when using 
a 0.7 mm tip compared to a 0.3 mm tip (P = 0.017). 
In our study, we attempted to increase the time 
before myringotomy closure by undertaking this procedure 
with 0.7 mm tip radiofrequency microcauteries and asso-
ciating mitomycin C. This substance is an aminoglycoside 
antibiotic with anticancer properties; it is able to interrupt 
DNA replication by inhibiting mitosis and protein synthesis. 
Topical mitomycin C may inhibit fibroblast proliferation 
in the tympanic membrane, which would delay healing.22 
Ragab et al. (2002 to 2004) studied 120 ears of chil-
dren (1-12 years, mean age 5 years) with a diagnosis of 
OME. These patients were randomized as folllows: radio-
frequency myringotomy and radiofrequency myringotomy 
with mitomycin. These authors found a mean 5.3 week 
closure time with myringotomy associated with mitomycin 
C. Using radiofrequency only resulted in a mean 3.5 week 
closure time. The authors concluded that mitomycin C 
prolongs the myringotomy patency time and stressed that 
the effectiveness of this substance appears to be increased 
in the presence of middle ear inflammation.23 
Lachan et al. (2005) published an experimental 
study in rabbits to compare radiofrequency only with 
radiofrequency associated with mitomycin C. The group 
undergoing myringotomy associated with mitomycin C 
had a mean 5.45 week patency, compared to the radio-
frequency technique only, wit a mean 1.60 weeks. The 
authors concluded that mitomycin C is an effective method 
to extend the myringotomy patency time.24 
Table 1. Comparison of myringotomy healing time among groups. 
 Days - median (interquartile range P25-75) 
Ear Group ** (n=12) Group  2** (n=10) Group  3** (n=15)
Right (control) 3 (3 a 3)
P*=0.023
3 (3 a 3)
P*=0,007
7 (3 a 7)
P*<0,001
Left 5 (3 a 7) 10 (7 a 14) 14 (10 a 30)
* Comparison among groups of left and right ears (sample and control ear) - Wilcoxon test 
** Comparison of left ears among groups: group 1 vs. Group 2 - P = 0.012, group 1 vs. Group 3 - P <0.001, vs group 2. Group 3 - P = 0.004 
Source: The Author (2007) 
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These authors carried a later experimental study in 
rabbits to compare laser and radiofrequency myringotomy 
only or associated with mitomycin C. This study showed 
no difference in healing time between both techniques 
isolatedly. However, associating mitomycin C prolonged 
the patency similarly in both techniques. The authors 
pointed out that since there was no statistically signifi-
cant difference between both procedures (CO
2
 laser and 
radiofrequency), radiofrequency could be an interesting 
alternative to laser, due to its safety, low cost and ease of 
handling. Associating mitomycin C, in their study, helped 
prolong the myringotomy patency time.25 
Wenzel et al. studied radiofrequency myringotomy 
without mitomycin C in 83 children with OME. Results were 
quite satisfactory, the average myringotomy healing time 
being 2.83 months (standard deviation = 1.39).26 
Radiofrequency myringotomy (0.7 mm tip) associa-
ted with mitomycin C, as presented in our study, demons-
trated a more statistically significant increase compared to 
the first two study groups (radiofrequency 0.7 mm and 
0.3 mm tips); the maximum tympanic membrane healing 
time was 44 days (the median was 14 days). 
Our study results diverged from those presented in 
the four studies above on radiofrequency myringotomy. 
These results may be due to the fact that Wenzel et al.’s 
26 and Ragab et al.’s 23 studies carried out myringotomy in 
children with middle ear effusion. MIddle ear inflammation 
appears to prolong patency. Additionally, the myringotomy 
diameter in their subjects was larger than in the animals 
in our study. 
The other 2 studies by Lachanas et al.24.25 used ra-
bbits, whereas we used Wistar rats. Moreover, the radio-
frequency current power and the device were different in 
our study. The maximum power of our device is 35 watts; 
we used the power 8 setting (operation mode timed in 1.5 
seconds) for obtaining about 30 Watts. Lachanas et al. did 
not report exposure times to the radiofrequency current 
on the tympanic membrane. These factors may have con-
tributed to lower myringotomy closure times in our study. 
Jassir et al. showed a dose-response curve for the 
topical application of mitomycin C; a 0.4 mg/ml dose 
resulted in a longer patency time compared to 0.05 mg/
ml and 0.2mg/ml. However, a 2.0 mg/ml dose did not 
increase the patency, and was associated in most cases 
with otorrhea. Otoacoustic emissions were carried out 
after the procedure and revealed no cochlear damage.27,28 
Jang et al., in a study of the effects of mitomycin C 
on a tympanic membrane fibroblast culture, concluded that 
the most significant antiproliferative effect was attained at 
a 0.4 mg/ml concentration applied during 10 minutes.22 
As a result of these studies, we adopted what was 
considered the most effective dose and duration of use of 
mitomycin C: 0.4mg/ml during 10 minutes. 
In our study, mitomycin C did not trigger otorrhea 
in our sample animals. We did not investigate cochlear 
function after mitomycin use. 
Our results showed that patency after radiofre-
quency myringotomy was more protracted than patency 
following microlancet myringotomy. There was also a 
significant increase in patency when mitomycin C was 
associated, showing that this technique may be an optional 
and effective method for myringotomy with VT insertion. 
Radiofrequency myringotomy has a number of 
advantages over laser myringotomy, namely lower cost, 
simpler handling, heat is concentrated in the tip resulting in 
increased accuracy, and the tip may be angled as required. 
Thus, microcauteries are superior to laser in that the latter 
may be restricted depending on the angle of incident rays.20 
It is important to emphasize that our study was con-
ducted in rats in which the tympanic membrane diameter 
is much smaller than  that in humans; hence, myringotomy 
diameters were less than those typically done in humans. 
Furthermore, our study was done in ears without active 
otitis, that is, with no middle ear mucosa inflammation. 
Consequently, myringotomy closure times may have been 
lower, since the presence of a pathological process in the 
middle ear interferes with the quantitative analysis of the 
patency period. Future studies may confirm this hypothe-
sis, by causing otitis media with effusion in experimental 
animals. 
CONCLUSION 
This study demonstrated that radiofrequency micro-
electrocautery myringotomy showed a statistically signi-
ficant difference in myringotomy healing time compared 
to microlancet myringotomy. Mitomycin C associated with 
the radiofrequency myringotomy (0.7 mm tip) method 
increased the patency period, with statistically significant 
results (P <0.01). 
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